baber/WOPTO huggingface dataset:
Patent AU-2001282758-B2 (AU)
Title: A sheet element and its use
Inventor: LINDSKOG KJELL
IPC: E05G1/024
Filed: 2001-08-07
Granted: 2007-08-09
Abstract: The invention relates to a sheet element (<bold>10</highlight>) that has integrated therewith an alarm mat (<bold>2</highlight>) and that is intended particularly for security containers and security spaces. The alarm mat (<bold>2</highlight>) is comprised of light-conducting and/or current-conducting filaments or like devices. The alarm mat (<bold>2</highlight>) includes a base mat (<bold>2</highlight><italic>a</highlight>) and a supplemental mat (<bold>2</highlight><italic>b</highlight>). The base mat (<bold>2</highlight><italic>a</highlight>) has an essentially looped filament pattern of the kind, for instance, obtained with knitting or crocheting. The supplemental mat (<bold>3</highlight><italic>b</highlight>) has a regular or irregular filament pattern. The base mat (<bold>2</highlight><italic>a</highlight>) and the supplemental mat (<bold>2</highlight><italic>b</highlight>) are tightly positioned together to form an alarm mat, wherewith the filament pattern of the base mat (<bold>2</highlight><italic>a</highlight>) and the filament pattern of the supplemental mat (<bold>2</highlight><italic>b</highlight>) deviate from totally coincidental overlap. The invention also relates to the use of the sheet element (<bold>10</highlight>) as casing material in a container (<bold>20</highlight>) or in a space intended for the storage of theft-attractive objects or the like.
Patent AU-2001286841-B2 (AU)
Title: Method and apparatus for detecting on-line homogeneity
Inventor: WALKER DWIGHT SHEROD
IPC: B01F29/62
Filed: 2001-08-28
Granted: 2004-10-21
Abstract: A method and apparatus for detecting on-line the homogeneity and constituent concentration of pharmaceutical compositions comprising mixing means for mixing the compositions of matter; and spectroscopic means for detecting on-line the homogeneity and constituent concentration of the compositions of matter, the spectroscopic means including a plurality of spectroscopic detection means disposed on the mixing means for providing light to the compositions of matter and detecting emission light from the compositions of matter, first control means for providing the light to the plurality of spectroscopic detection means and analyzing the emission light from the plurality of spectroscopic detection means, and second control means in communication with the first control means and the plurality of spectroscopic detection means for controlling the transmission of the light from the first control means to the plurality of spectroscopic detection means and the emission light from the plurality of spectroscopic detection means to the first control means, the second control means including switch means for connecting a respective one of the plurality of spectroscopic detection means to the first control means.
Patent AU-2002223814-B2 (AU)
Title: Small acid-soluble spore protein and uses thereof
Inventor: FAIRHEAD HEATHER MARIE
IPC: A01N63/50
Filed: 2001-11-16
Granted: 2007-08-30
Abstract: A polypeptide having α/β type SASP activity, for use as a medicament.
Patent AU-2002247652-B2 (AU)
Title: Method for preparing composite materials containing natural binders
Inventor: GUILBERT STEPHANE
IPC: C08L89/00
Filed: 2002-01-21
Granted: 2007-01-18
Abstract: The invention relates to a method for preparing natural fibre-based composite materials containing natural binders and powdery proteins, comprising the following steps; adding a powdery protein adhesive binder to natural fibres having a moisture content of 1 15%; mixing the natural fibres together with the powdery protein adhesive; adjusting the moisture content of the composition to 6 24% w/w; and submitting the mixture to a heat pressure treatment to form the natural fibre-based material.
Patent AU-2002334935-B2 (AU)
Title: Powder processing with pressurized gaseous fluids
Inventor: SAIM SAID
IPC: A61K47/26
Filed: 2002-10-10
Granted: 2008-04-03
Abstract: Disclosed is a method of small particle precipitation, retention and dispersion of a solid or semi-solid material onto or into a carrier material. In this method, solute particles are precipitated from a pressurized gaseous fluid solution or a liquid solution and effectively retained and dispersed within a carrier material. This technique can be advantageously used in pharmaceutical processing to produce a blend of solid or semi-solid material particles and carrier material, a granulation of the solid or semi-solid material particles with carrier material, carrier material partially or fully coated with the solid or semi-solid material particles, or mixtures thereof.
Patent AU-2003200691-B2 (AU)
Title: Vascular filter system for cardiopulmonary bypass
Inventor: WELCH JEFFREY
IPC: A61B17/22
Filed: 2003-02-25
Granted: 2008-02-14
Abstract: A cardiopulmonary bypass filter system comprises a housing (366) having distal and proximal ends, the proximal end comprising a connector (372) adapted to connect to at least one hose (360) and the distal end comprising a distal member (370) having first and second openings. The housing has a first lumen (374) adapted to be in fluid communication with the at least one hose (360) and one of the first and second openings (388), and also a second lumen (378) which extends from a port (380) to the other of the first and second openings (384) in the housing distal member. The filter system (394) includes a vascular filter system comprising a collapsible filter (394) which can be advanced through the housing port (380), said vascular filter system comprising (a) a filter membrane (400) support structure, and (b) a filter membrane (170) attached to said filter membrane support structure, said filter membrane having openings (190), wherein said openings (190) have variable diameters, and wherein the diameter of said openings (190) range from about 20 to about 300 microns.
Patent AU-2003217386-B2 (AU)
Title: Humanized GM-CSF antibodies
Inventor: SCOTT ANDREW
IPC: C07K16/40
Filed: 2003-02-12
Granted: 2008-06-26
Abstract: Chimeric antibodies, as well as fusion proteins which comprise chimeric antibodies, are disclosed. The antibodies bind to GM-CSF, CD-30, and G250 antigen. The fusion proteins include biologically active portions of tumor necrosis factor, or full length tumor necrosis factor. Expression vectors adapted for production of the antibodies, as well as methods for manufacturing these, are also disclosed.
Patent AU-2003239062-B2 (AU)
Title: Multi-material incontinence treatment constriction device
Inventor: FORSELL PETER
IPC: A61L31/08
Filed: 2003-06-19
Granted: 2008-09-18
Abstract: An implantable constriction device for treating an incontinent patient comprises an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient. The elongate composite structure is composed of a base material, such as hard silicone, making the composite structure self-supporting. Property improving material is provided for improving at least one physical property of the composite structure other than self-supporting properties, such as fatigue resistance, liquid impermeability, aggressive body cells resistance, anti-friction properties and lifetime.
Patent AU-2003248435-B2 (AU)
Title: Modified system and method for intraoperative tension assessment during joint arthroplasty
Inventor: HELDRETH MARK A
IPC: A61F2/30
Filed: 2003-09-29
Granted: 2009-08-06
Abstract: The system has a flexible sensor array (26) capable of being shaped to define a curved contour and generating a signal in response to pressure. A protector (28A) has a curved, contoured articulating surface and is capable of transmitting pressure to the sensor array. Mounting units are associated with the protector and one of trials for securing the protector and the trial.
Patent AU-2004202730-B2 (AU)
Title: Detection of out of memory and graceful shutdown
Inventor: HASSAN AHMED
IPC: G06F11/30
Filed: 2004-06-23
Granted: 2008-09-04
Abstract: The method involves reserving a buffer within a block of memory, where the buffer is unavailable to an application (144 1-144-N) until released. The reserve buffer is released for use by the application upon determining that memory use by the application has reached a threshold. A warning signal is generated upon determining that the memory use by the application has reached the threshold. An independent claim is also included for a system for managing low memory on a computer device.
Patent AU-2004208696-B2 (AU)
Title: Pipe joint with defined sealing effect
Inventor: SCHWAIM DIETER
IPC: F16L13/14
Filed: 2004-09-03
Granted: 2006-03-09
Abstract: The subject matter of this present invention is a pipe joint with a socket ( 1 ) and a pipe ( 2 ), that is closed by pushing a ring ( 3 ) onto the socket ( 1 ). The joint further comprises a sealing element ( 4 ) that is placed into a chamber ( 5 ) of the socket ( 1 ). The chamber is executed as a diametral expansion of the socket ( 1 ) and is deformed in a defined manner when the ring ( 3 ) is pushed on. Due to this the sealing element ( 4 ) between the wall of the chamber ( 5 ) and the pipe ( 2 ) is compressed. Furthermore, when the joint is closed, the socket ( 1 ) is compressed with the pipe ( 2 ), due to which a mechanically stable joint is produced, that additionally serves as an emergency seal.
Patent AU-2004260779-B2 (AU)
Title: Meldonium salts, method of their preparation and pharmaceutical composition on their basis
Inventor: BIRMANS ANATOLIJS
IPC: A61K9/52
Filed: 2004-07-15
Granted: 2009-01-22
Abstract: New salts of Meldonium, the method of their preparation, and pharmaceutical formulation on their basis have been described. The general formula of these salts is X<SUP>-</SUP>(CH3)3N+NHCH2CH2COOH where X<SUP>-</SUP> is an acid anion selected from the group of pharmaceutically acceptable acids. Practically non-hygroscopic and/or increased thermal stability and/or lasting action Meldonium hydrogen salts of fumaric acid, phosphoric acid, oxalic acid, maleic acid, and pamoic acid as well as Meldonium orotate and galactarate are especially suitable. Novel pharmaceutical formulations containing non-hygroscopic and/or increased thermal stability and/or and/or lasting action 3-(2,2,2-trimethylhydrazinium) propionate salts for oral parenteral, rectal, and transdermal introduction are concurrently described.
Patent AU-2004322123-B2 (AU)
Title: Lysine based compounds
Inventor: STRANIX BRENT RICHARD
IPC: C07D405/12
Filed: 2004-08-02
Granted: 2009-08-13
Abstract: The present invention provides lysine based compositions which include both an HIV antiviral or anti-retroviral agent and a compound of the formula;   
wherein R 1  may be, for example, (HO) 2 P(O)-, (NaO) 2 P(O)-, alkyl-CO- or cycloalkyl-CO-, wherein X and Y may be, for example, H, alkyl, cycloalkyl, F, Cl, Br, I or any of a range of other defined functional groups, wherein n is 3 or 4 and wherein R 2  , R 3  and R 6  are as defined herein.
Patent AU-2005273430-B2 (AU)
Title: Methods for producing isoindole derivatives
Inventor: TAIJU NAKAMURA
IPC: C07C255/59
Filed: 2005-07-27
Granted: 2011-06-30
Abstract: A process for the production of isoindole derivatives (compounds (II)) represented by the general formula (II) or salts thereof: (II) [wherein R and R are each independently C alkyl], which comprises the step (1) of cyclizing a compound (I) represented by the general formula (I) or a salt thereof, or a hydrate or solvate of either in a solvent in the presence of a base: (I) [wherein R and R are each as defined above].
Patent AU-2005292296-B2 (AU)
Title: One step fire ant control
Inventor: STEWARD VICTOR BRUCE
IPC: A01N43/40
Filed: 2005-09-27
Granted: 2012-02-02
Abstract: The present invention relates to a method for controlling fire ants with a single step application of a combination of a bait and a controlled release treatment composition, and to the novel bait/controlled release treatment composition combination used in the method of the present invention.
Patent AU-2005309143-B2 (AU)
Title: Edible container for foodstuffs and process for producing the same
Inventor: WOLFGANG GAENG
IPC: A23G9/50
Filed: 2005-10-11
Granted: 2011-08-18
Abstract: An open-ended edible container for foodstuffs composed of cereals and/or fruits in a sheet formed by means of a binder wherein the inner surface of the container is very lightly patterned while the outer surface has a smooth texture with embedded flakes; a process for manufacturing edible containers for foodstuffs comprising the steps of: pouring a liquid batter on baking plates, partially cooking the batter for providing a sheet, depositing cereals and/or fruit flakes as a layer onto the sheet, -finally cooking the sheet, giving the desired shape to the container, in which the inner surface of the container is very lightly patterned while the outer surface of said container has a rough texture with embedded flakes.
Patent AU-2006201329-B2 (AU)
Title: Body attachable sanitary protection article including tactile placement aid
Inventor: MICHAEL MOSCHEROSCH H
IPC: A61F13/51
Filed: 2006-03-30
Granted: 2011-11-03
Abstract: An absorbent article (20) including a liquid pervious cover (42), a liquid impermeable barrier (50), a body facing surface (25), a garment facing surface (27), an 5 adhesive (33) for securing the article (20) to the body arranged on the body facing surface (45), and a tactile placement aid (60) that is tactilely perceptible to a user from the garment facing surface (27) of the article (20).
Patent AU-2006212385-B2 (AU)
Title: Replication-deficient RNA viruses as vaccines
Inventor: SASCHA BOSSOW
IPC: A61K48/00
Filed: 2006-02-10
Granted: 2011-12-15
Abstract: The invention relates to a genome replication-deficient and transcription-competent negative strand RNA virus which can be used for expressing transgenes and especially for developing vaccines. The viral genome contains a mutation in at least one of the genes N, L, or P.
Patent AU-2006226627-B2 (AU)
Title: Use of the Mst protein for the treatment of a thromboembolic disorder
Inventor: ALEXANDER RUECK
IPC: A61P9/10
Filed: 2006-03-20
Granted: 2011-12-22
Abstract: The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein.
Patent AU-2006230337-B2 (AU)
Title: Heteroaryl urea derivatives useful for inhibiting Chk1
Inventor: WADE COOK ADAM
IPC: A61K31/5355
Filed: 2006-03-29
Granted: 2011-10-27
Abstract: Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.
Patent AU-2006240324-B2 (AU)
Title: Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
Inventor: IBANEZ JUAN JOSE LEGARDA
IPC: A61K31/551
Filed: 2006-04-07
Granted: 2010-02-25
Abstract: The invention relates to methods of and treatments for using pharmaceutical compositions from a class of compounds that directly or indirectly selectively modulates GABAA chloride channel activity to treat alcohol and/or stimulant substance abuse. The present invention also relates to methods of, and protocols for, relieving symptoms associated with alcohol and/or stimulant substance abuse in a comprehensive treatment plan. More specifically, the present invention relates to the use of a selective chloride channel modulator, such as flumazenil, to treat alcohol and/or psychostimulant dependency, the withdrawal symptoms associated therewith, and the cravings associated therewith.
Patent AU-2006243234-B2 (AU)
Title: Installation for implementing a method for producing paper pulp, lignins and sugars and production method using such an installation
Inventor: DELMAS MICHEL
IPC: D21C3/20
Filed: 2006-04-20
Granted: 2010-10-28
Abstract: The invention proposes an installation (10) in which the impregnation and fractionation of the raw material (MP) are conducted at atmospheric pressure, characterized in that it comprises means (18, 20) for transferring the raw material (MP) successively to a first treatment station (PT1) and a second treatment station (PT2), each comprising means (G1, G2) for temporarily combining, at the first station (PT1), the raw material (MP) with a quantity of a first mixture of organic acids and, at the second station (PT2), for temporarily combining the raw material (MP) with a quantity of a second mixture; and means, after impregnation, for at least partially recovering the quantity of second mixture after impregnation and for recycling at least a portion of the second recovered mixture to form at least partially said first impregnation mixture used at the first station (PT1).
Patent AU-2006252319-B2 (AU)
Title: Cabinet type endoscope processor
Inventor: LIN SZU-MIN
IPC: A61L2/18
Filed: 2006-12-28
Granted: 2012-12-06
Abstract: An endoscope processor, according to the present invention, provides for cleaning and sterilizing an endoscope having a body, and a first flexible tube 5 attached to the body. It includes an operational housing and an enclosure which is attachable to and detachable from the operational housing, the enclosure being sealed from ingress of potentially contaminating microorganisms when detached from the operational housing. The enclosure is shaped, sized and oriented to receive the endoscope in an orientation with the first flexible tube depending vertically 10 downwardly from the endoscope body. The enclosure includes a liquid inlet and a liquid outlet. The operational housing includes a circulating system comprising at least one liquid pump having a pump outlet connected to the liquid inlet of the enclosure when the enclosure is attached to the operational housing, and a pump inlet connected to the liquid outlet of the enclosure when the enclosure is attached to the 15 operational housing, whereby to circulate liquid through the enclosure. A source of sterilizing fluid is associated with the pump and a control system is programmed to control a sterilization procedure whereby the pump circulates a liquid comprising the sterilizing fluid through the enclosure. 20/12/06,16254 specification,2
Patent AU-2006291320-B2 (AU)
Title: Method, apparatus, and program product for presenting gaming results through inverse symbol logic
Inventor: TANNER SVANAS GALEN
IPC: A63F9/24
Filed: 2006-08-30
Granted: 2012-01-12
Abstract: A method displays a number of symbol locations (40 1-4 10) with a respective graphic symbol at each symbol location. This group of presentation symbols includes a target symbol (41 1 ). In response to a first player input, each of the number of symbol locations (401-410) is caused to conduct a respective symbol change process (303) one or more times to change the graphic symbol included at each respective symbol location (401-410) to a respective one of the graphic symbols included in the group of presentation symbols. According to the invention, at least some of the awards available in the game are based at least in part on the absence of the target symbol (41 1 ) at one or more of the number of symbol locations.
Patent AU-2006293613-B2 (AU)
Title: PDGF amphiphilic polymer complex
Inventor: SOULA OLIVIER
IPC: A61K38/18
Filed: 2006-09-26
Granted: 2012-05-17
Abstract: The invention concerns novel platelet-derived growth factor (PDGF) complexes associated with amphiphilic polymers for enhancing the physical and chemical and stability of the therapeutic protein for pharmaceutical applications. The invention also concerns a method for preparing the PDGF-amphiphilic polymer complex characterized in that it consists in preparing said polymer/PDGF-BB complex in an aqueous medium and in the absence of organic solvent likely to cause denaturation of the protein and the use of said PDGF-amphiphilic polymer complex for preparing a therapeutic wound-healing composition for topically treating ulcers.
Patent AU-2006302483-B2 (AU)
Title: Thermally enhanced solid-state generator
Inventor: BERETICH THOMAS
IPC: H01G9/21
Filed: 2006-10-04
Granted: 2012-07-05
Abstract: A solid state energy conversion device along with its production methods and systems of use is provided. The device in its most basic form consists of two layers, in contact with each other, of dissimilar materials in terms of electron density and configuration, sandwiched between metal layers, which serve as the anode and cathode of the device. One of the inside layers is made of a stabilized mixture of carbon and an ionic material (carbon matrix). The other inner material consists of a stabilized oxide mixed with an ionic material (oxide matrix). This device takes advantage of the built-in potential that forms across the barrier between the carbon matrix and the oxide matrix. The built-in potential of the device (when not attached to a resistive load at the terminals), which is determined mathematically by integrating the electrostatic forces that have created themselves across the barrier, will rise or fall in direct proportion to the rise and fall of the device temperature (in kelvins). When a load is attached across the terminals of the device, current flows. Depending on the size of the load or the surface area of the device, a reduced current will allow sustained recombination such that the built-in potential and current remains steady overtime. Otherwise, the current curve will fall over time similar to a capacitor device. Experimentation shows that current rises by the fourth power of the temperature factor.
Patent AU-2006318880-B2 (AU)
Title: Composition and method
Inventor: VAN LOYEN DIETMAR
IPC: C11D3/20
Filed: 2006-11-23
Granted: 2012-09-27
Abstract: A low-foaming composition for cleaning a ware-washing machine comprises water, an alkoxylate, an acid (preferably citric acid) , and preferably a phase separation promoter (for example a polyethylene glycol or an ionic salt). The composition is in two separate layers under ambient conditions.
Patent AU-2006325322-B2 (AU)
Title: Aspartic protease inhibitors
Inventor: WEI ZHAO
IPC: C07D417/06
Filed: 2006-11-13
Granted: 2011-08-04
Abstract: The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.
Patent AU-2007215822-B2 (AU)
Title: External preparation for skin containing flavanone derivative
Inventor: TADA AKIHIRO
IPC: A61P17/16
Filed: 2007-02-15
Granted: 2012-10-25
Abstract: To increase a tissue regeneration ability of a living body such as a collagen production ability of fibroblast in the dermis in a skin defect area typified by a large wrinkle or wound, a flavanone derivative such as farrerol is used as an active ingredient of an external preparation for skin. Further, to efficiently screen a substance having an excellent effect on promoting wound healing, the remodeling action of collagen fiber bundle is tested by using a skin wound model.